Common triggers for food protein-induced enterocolitis syndrome (FPIES) have shifted, and more cases than expected have ...
More than a third of food-allergic kids were able to eat full servings of their trigger foods after treatment with an ...
11h
HealthDay on MSNAAAAI: Omalizumab Superior to Oral Immunotherapy in Multifood AllergyOmalizumab is superior to oral immunotherapy (OIT) for multifood allergy, and most patients include dietary consumption (DC) ...
"The effect of formula supplementation spans beyond cow's milk allergy," Bhasin said, citing a prior randomized trial showing ...
KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the presentation of novel sebetralstat data related to ...
The study of success eating food triggers after stopping Xolair is ongoing, so researchers are still collecting data for doctors to use making treatment plans with their patients. Parents interested ...
FARE to Debut Two New Videos at AAAAI/WAO Joint Congress, Including PSA on Early Allergen Introduction and Documentary on ...
Roche’s asthma drug Xolair appears to be safer and more effective than oral immunotherapy at treating adults and children ...
Omalizumab works by binding to the allergy-causing antibody called immunoglobulin E in the blood and preventing it from ...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today new positive data from Stage 2 and Stage ...
A new study has revealed that the injectable asthma drug helped more than one-third of the kids to overcome their food ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results